M. Baldeyrou

606 total citations
8 papers, 179 citations indexed

About

M. Baldeyrou is a scholar working on Infectious Diseases, Surgery and Epidemiology. According to data from OpenAlex, M. Baldeyrou has authored 8 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in M. Baldeyrou's work include Orthopedic Infections and Treatments (4 papers), Infectious Diseases and Tuberculosis (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). M. Baldeyrou is often cited by papers focused on Orthopedic Infections and Treatments (4 papers), Infectious Diseases and Tuberculosis (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). M. Baldeyrou collaborates with scholars based in France. M. Baldeyrou's co-authors include Pierre Tattevin, Élisabeth Polard, François Bénézit, Christophe Paris, Ronan Garlantézec, Denis Mulleman, Nicolas Lefèbvre, Thomas Bauer, Raphaèle Séror and Robert Touitou and has published in prestigious journals such as Clinical Microbiology and Infection, HIV Medicine and Joint Bone Spine.

In The Last Decade

M. Baldeyrou

7 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Baldeyrou France 5 115 91 39 35 28 8 179
Yuzo Shimazu Japan 9 133 1.2× 89 1.0× 9 0.2× 6 0.2× 28 1.0× 21 218
Jacopo Garlasco Italy 7 35 0.3× 12 0.1× 9 0.2× 17 0.5× 25 0.9× 35 152
Joanne Batting South Africa 6 85 0.7× 58 0.6× 28 0.7× 4 0.1× 28 1.0× 16 136
Kirubel Eshetu Ethiopia 8 104 0.9× 16 0.2× 6 0.2× 42 1.2× 66 2.4× 19 147
Miriam Schneidman United States 7 54 0.5× 23 0.3× 18 0.5× 2 0.1× 20 0.7× 20 152
Jonathan Kitonsa Uganda 6 103 0.9× 36 0.4× 26 0.7× 2 0.1× 52 1.9× 15 146
Felix Ocom Uganda 6 55 0.5× 28 0.3× 12 0.3× 10 0.3× 12 0.4× 9 126
Peyton Thompson United States 9 64 0.6× 59 0.6× 6 0.2× 12 0.3× 106 3.8× 29 192
Julia Notter Switzerland 6 75 0.7× 57 0.6× 5 0.1× 2 0.1× 56 2.0× 20 151
Chimeremma Nnadi United States 8 116 1.0× 44 0.5× 6 0.2× 10 0.3× 63 2.3× 9 186

Countries citing papers authored by M. Baldeyrou

Since Specialization
Citations

This map shows the geographic impact of M. Baldeyrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Baldeyrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Baldeyrou more than expected).

Fields of papers citing papers by M. Baldeyrou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Baldeyrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Baldeyrou. The network helps show where M. Baldeyrou may publish in the future.

Co-authorship network of co-authors of M. Baldeyrou

This figure shows the co-authorship network connecting the top 25 collaborators of M. Baldeyrou. A scholar is included among the top collaborators of M. Baldeyrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Baldeyrou. M. Baldeyrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Saade, Anastasia, David Luque-Paz, M. Baldeyrou, et al.. (2022). Microbiology and antibiotics after second-stage revision of periprosthetic joint infections: A two-year follow-up cohort. Infectious Diseases Now. 52(6). 358–364. 3 indexed citations
2.
Paris, Christophe, François Bénézit, Élisabeth Polard, et al.. (2021). COVID-19 vaccine hesitancy among healthcare workers. Infectious Diseases Now. 51(5). 484–487. 101 indexed citations
3.
Couderc, Marion, Géraldine Bart, Guillaume Coiffier, et al.. (2020). 2020 French recommendations on the management of septic arthritis in an adult native joint. Joint Bone Spine. 87(6). 538–547. 30 indexed citations
4.
Bénézit, François, Damien Luque Paz, Charlotte Pronier, et al.. (2020). Histoire naturelle de la COVID-19 avec suivi prospectif systématique standardisé : combien de temps durent les symptômes ?. Médecine et Maladies Infectieuses. 50(6). S79–S79.
5.
Couderc, Marion, Géraldine Bart, Guillaume Coiffier, et al.. (2020). Recommandations françaises 2020 sur la prise en charge des arthrites septiques sur articulation native de l’adulte. Revue du Rhumatisme. 87(6). 428–438. 4 indexed citations
6.
Baldeyrou, M. & Pierre Tattevin. (2018). Infecciones urinarias. EMC - Tratado de Medicina. 22(2). 1–8. 3 indexed citations
7.
Argemi, Xavier, Gilles Prévost, P. Riegel, et al.. (2016). VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis. Clinical Microbiology and Infection. 23(5). 334.e1–334.e8. 27 indexed citations
8.
Gantner, Pierre, M Partisani, M. Baldeyrou, et al.. (2014). Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV‐1‐infected patients: a cohort study. HIV Medicine. 16(2). 132–136. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026